302sek
2,4 %
Date:2025-06-04Time:18:00:00Latest report:Q4-2023List:First NorthTicker:PILA
Market Cap:82 msekEnterprise Value:76 msekNet Sales:1,46 msekEarnings:-9,93 msekEmployees:0ISIN:SE0015988274

Ratios

10-year key figure history for Pila Pharma turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Pila Pharma with index and moving average MA50 and MA200.

Stockprice:3,02
MA50:3,09
MA200:4,11
Price/MA200:-26,6 %
RSI (14):49,3
Price/MA50:-2,3 %

Description

PILA PHARMA is a clinical stage biotechnology company based in Malmö, Sweden. The company is developing novel oral therapeutics for globally common metabolic diseases such as Diabetes, Obesity and Cardiovascular diseases as well as therapeutics for Pain treatment. The company has obtained an orphan drug designation in the United States for the painful rare disease Erythromelalgia. The company is specializing in development of pharmaceutical drugs based on TRPV1-antagonists.

Pharmaceuticals